FDA to use enforcement discretion on whole-grains health claims

The FDA says there is limited evidence to support health claims that whole-grain consumption can reduce diabetes risk, and that it will use its enforcement discretion for two food-label claims that whole grains may reduce the risk of type 2 diabetes. Food manufacturers are permitted to make the claims if they are worded in a manner that does not mislead consumers.

View Full Article in:

FoodBusinessNews.net (free registration) · CandyAndSnackToday.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA